Inflammation-mediated skin tumorigenesis induced by epidermal c-Fos

• Verfasst von: Briso, Eva M. [VerfasserIn]
• Verfasst von: Guinea-Viniegra, Juan [VerfasserIn]
• Verfasst von: Bakiri, Latifa [VerfasserIn]
• Verfasst von: Rogon-Lamparski, Zbigniew [VerfasserIn]
• Verfasst von: Petzelbauer, Peter [VerfasserIn]
• Verfasst von: Eils, Roland [VerfasserIn]
• Verfasst von: Wolf, Ronald [VerfasserIn]
• Verfasst von: Rincón, Mercedes [VerfasserIn]
• Verfasst von: Angel, Peter [VerfasserIn]
• Verfasst von: Wagner, Erwin F. [VerfasserIn]
• Titel: Inflammation-mediated skin tumorigenesis induced by epidermal c-Fos
• Verf.angabe: Eva M. Briso, Juan Guinea-Viniegra, Latifa Bakiri, Zbigniew Rogon, Peter Petzelbauer, Roland Eils, Ronald Wolf, Mercedes Rincón, Peter Angel, and Erwin F. Wagner
• E-Jahr: 2013
• Jahr: September 12, 2013
• Umfang: 15 S.
• Fussnoten: Gesehen am 07.12.2020
• Titel Quelle: Enthalten in: Genes & development
• Ort Quelle: Stanford, Calif. : HighWire Press, 1987
• Jahr Quelle: 2013
• Band/Heft Quelle: 27(2013), 18, Seite 1959-1973
• ISSN Quelle: 1549-5477
• DOI: doi:10.1101/gad.223339.113
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: AP-1
• Sach-SW: c-Fos
• Sach-SW: cancer
• Sach-SW: CD4 T cell
• Sach-SW: inflammation
• Sach-SW: skin
• K10plus-PPN: 1742197752

Abstract

Skin squamous cell carcinomas (SCCs) are the second most prevalent skin cancers. Chronic skin inflammation has been associated with the development of SCCs, but the contribution of skin inflammation to SCC development remains largely unknown. In this study, we demonstrate that inducible expression of c-fos in the epidermis of adult mice is sufficient to promote inflammation-mediated epidermal hyperplasia, leading to the development of preneoplastic lesions. Interestingly, c-Fos transcriptionally controls mmp10 and s100a7a15 expression in keratinocytes, subsequently leading to CD4 T-cell recruitment to the skin, thereby promoting epidermal hyperplasia that is likely induced by CD4 T-cell-derived IL-22. Combining inducible c-fos expression in the epidermis with a single dose of the carcinogen 7,12-dimethylbenz(a)anthracene (DMBA) leads to the development of highly invasive SCCs, which are prevented by using the anti-inflammatory drug sulindac. Moreover, human SCCs display a correlation between c-FOS expression and elevated levels of MMP10 and S100A15 proteins as well as CD4 T-cell infiltration. Our studies demonstrate a bidirectional cross-talk between premalignant keratinocytes and infiltrating CD4 T cells in SCC development. Therefore, targeting inflammation along with the newly identified targets, such as MMP10 and S100A15, represents promising therapeutic strategies to treat SCCs.